Elan gets positive opinion on TYSABRI drug from EMEA science ...
Forbes - USA
... the scientific committee of the European Medicines Agency has issued a positive opinion recommending marketing authorization for its TYSABRI multiple sclerosis ...

ADR Report: Latin America Issues Lead Overall ADR Climb
Yahoo! News - USA
... to $14.70 as the scientific committee of the European Medicines Agency recommended the return to market of its key drug, multiple-sclerosis treatment Tysabri. ...

Recommendations on Tysabri release restriction
RTE.ie - Ireland
The European Medicine's Agency (EMA) has recommended that the multiple sclerosis treatment drug, Tysabri, should be made available to patients on a restricted ...
See all stories on this topic

Stocks Down Following Microsoft Outlook
Forbes - USA
... said the scientific committee of the European Medical Agency issued a positive opinion about recommending marketing authorization for Tysabri, the multiple ...

Woman with MS hopes for relief
LaCrosse Tribune - LaCrosse,WI,USA
... The Holmen, Wis., woman used Tysabri, which was withdrawn in February 2005 after only four months on the market when three people in clinical trials developed ...

More Good News for Tysabri
TheStreet.com - USA
An advisory committee to European drug regulators is recommending that Tysabri, the multiple sclerosis drug from Biogen Idec (BIIB:Nasdaq - commentary ...
See all stories on this topic